FGWLF yields 3.44% · JNJ yields 2.13%● Live data
📍 FGWLF pulled ahead of the other in Year 1
Combined, FGWLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FGWLF + JNJ for your $10,000?
Flughafen Wien Aktiengesellschaft, together with its subsidiaries, engages in the construction and operation of civil airports and related facilities in Austria. It manages the Vienna airport. The company operates through five segments: Airport, Handling & Security Services, Retail & Properties, Malta, and Other. The company's Airport segment operates and maintains aircraft movement areas and terminals, as well as equipment and facilities for passenger and baggage handling, as well as security controls for passengers. This segment also offers various services to support airport operations, deal with emergencies and disruptions, and ensure security. Its Handling & Security services segment provides various services for the handling of aircraft and passengers on scheduled and charter flights, as well as for the handling of general aviation aircraft and passengers. This segment also operates the general aviation center; and provides security controls for passengers and hand luggage. The company's Retail & Properties segment offers services that support airport operations, including shopping, food and beverages, VIP, lounges, and parking, as well as develops and markets properties. Its Malta segment operates Malta airport; and provides parking services, as well as rents retail and office space. The Other segment offers technical and repair, energy supply and waste disposal, telecommunication, and information technology, electromechanical and building, construction management, and consulting services, as well as construction and maintenance services for infrastructure facilities. The company is headquartered in Schwechat, Austria.
Full FGWLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.